CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,454,883 | -44.4% | 53,400 | -54.6% | 0.06% | -40.0% |
| Q2 2023 | $2,615,643 | +61.2% | 117,557 | +56.9% | 0.10% | +59.1% |
| Q1 2023 | $1,622,789 | +118179.1% | 74,921 | +10.9% | 0.07% | +11.9% |
| Q4 2022 | $1,372 | -99.9% | 67,539 | 0.0% | 0.06% | -26.2% |
| Q3 2022 | $1,732,000 | +7.8% | 67,539 | 0.0% | 0.08% | +14.3% |
| Q2 2022 | $1,606,000 | +10.8% | 67,539 | +4.9% | 0.07% | +32.1% |
| Q1 2022 | $1,449,000 | +7.1% | 64,357 | -5.9% | 0.05% | +12.8% |
| Q4 2021 | $1,353,000 | -8.0% | 68,357 | -8.5% | 0.05% | -20.3% |
| Q3 2021 | $1,470,000 | +66.7% | 74,717 | +86.4% | 0.06% | +63.9% |
| Q2 2021 | $882,000 | -7.5% | 40,089 | 0.0% | 0.04% | -14.3% |
| Q1 2021 | $954,000 | -8.5% | 40,089 | +0.5% | 0.04% | -16.0% |
| Q4 2020 | $1,043,000 | +50.3% | 39,889 | 0.0% | 0.05% | +31.6% |
| Q3 2020 | $694,000 | +3.4% | 39,889 | 0.0% | 0.04% | 0.0% |
| Q2 2020 | $671,000 | – | 39,889 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,003,723 | $95,164,000 | 6.41% |
| TANAKA CAPITAL MANAGEMENT INC | 65,609 | $780,000 | 3.41% |
| S&T BANK/PA | 588,620 | $6,999,000 | 1.93% |
| Parallel Advisors, LLC | 1,405,895 | $16,716,000 | 1.35% |
| Matarin Capital Management, LLC | 623,915 | $7,418,000 | 1.15% |
| AJ WEALTH STRATEGIES, LLC | 668,020 | $7,943,000 | 1.08% |
| Capital Impact Advisors, LLC | 177,300 | $2,108,000 | 0.88% |
| Alambic Investment Management, L.P. | 29,547 | $351,000 | 0.85% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 332,436 | $3,953,000 | 0.79% |
| Spark Investment Management LLC | 116,400 | $1,383,000 | 0.74% |